Connection

Peng Xia to Receptors, Fibroblast Growth Factor

This is a "connection" page, showing publications Peng Xia has written about Receptors, Fibroblast Growth Factor.
Connection Strength

0.552
  1. SOMCL-085, a novel multi-targeted FGFR inhibitor, displays potent anticancer activity in FGFR-addicted human cancer models. Acta Pharmacol Sin. 2018 Feb; 39(2):243-250.
    View in: PubMed
    Score: 0.362
  2. Design, synthesis and biological evaluation of a series of novel 2-benzamide-4-(6-oxy-N-methyl-1-naphthamide)-pyridine derivatives as potent fibroblast growth factor receptor (FGFR) inhibitors. Eur J Med Chem. 2018 Jun 25; 154:9-28.
    View in: PubMed
    Score: 0.190
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.